These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 8814753)
21. Use of chloramphenicol as topical eye medication: time to cry halt? Doona M; Walsh JB BMJ; 1995 May; 310(6989):1217-8. PubMed ID: 7767184 [No Abstract] [Full Text] [Related]
22. Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine. West BC; DeVault GA; Clement JC; Williams DM Rev Infect Dis; 1988; 10(5):1048-51. PubMed ID: 3055188 [TBL] [Abstract][Full Text] [Related]
23. Trends in ophthalmic antimicrobial utilization pattern in Bahrain between 1993 and 2000: a resurgence of chloramphenicol? Jassim Al Khaja KA; Sequeira RR; Mathur VS Int J Clin Pharmacol Ther; 2003 Jan; 41(1):36-41. PubMed ID: 12564744 [TBL] [Abstract][Full Text] [Related]
24. Is it time to stop using chloramphenicol on the eye? Risk is low in short courses. Hall AV; Das SS; Tabaqchali S BMJ; 1995 Aug; 311(7002):450-1; author reply 451. PubMed ID: 7640599 [No Abstract] [Full Text] [Related]
25. Widespread use of topical chloramphenicol. Ursell P Br J Ophthalmol; 1996 Sep; 80(9):854. PubMed ID: 8942390 [No Abstract] [Full Text] [Related]
26. [Topical use of chloramphenicol in ophthalmology]. López Alemany A; Presencia Redal A Gac Sanit; 1988; 2(9):294. PubMed ID: 3147267 [No Abstract] [Full Text] [Related]
27. Efficacy and adverse effects of topical chloramphenicol ointment use for surgical wounds: a systematic review. Shen AY; Haddad EJ; Hunter-Smith DJ; Rozen WM ANZ J Surg; 2018 Dec; 88(12):1243-1246. PubMed ID: 29573103 [TBL] [Abstract][Full Text] [Related]
33. A prospective study of chloramphenicol induced aplastic anaemia in Nigerians. Durosinmi MA; Ajayi AA Trop Geogr Med; 1993; 45(4):159-61. PubMed ID: 8236465 [TBL] [Abstract][Full Text] [Related]
34. Aplastic anemia and chloramphenicol. Davidoff E Am J Ophthalmol; 1982 Aug; 94(2):268-9. PubMed ID: 7114158 [No Abstract] [Full Text] [Related]
35. Drug-induced aplastic anaemia in Sweden with special reference to chloramphenicol. Böttiger LE Postgrad Med J; 1974 Oct; 50 Suppl 5():127-31. PubMed ID: 4470806 [No Abstract] [Full Text] [Related]
36. Topical application of chloramphenicol eye ointment followed by fatal bone marrow aplasia. Brodsky E; Biger Y; Zeidan Z; Schneider M Isr J Med Sci; 1989 Jan; 25(1):54. PubMed ID: 2925363 [No Abstract] [Full Text] [Related]
37. Blood dyscrasias and topically applied chloramphenicol in ophthalmology. Besamusca FW; Bastiaensen LA Doc Ophthalmol; 1986 Dec; 64(1):87-95. PubMed ID: 3582104 [TBL] [Abstract][Full Text] [Related]
38. Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms. Vincent PC Drugs; 1986 Jan; 31(1):52-63. PubMed ID: 3940848 [TBL] [Abstract][Full Text] [Related]
40. Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anaemia should give definitive answer. Gordon-Smith EC; Marsh JC; Geary CG BMJ; 1995 Aug; 311(7002):451. PubMed ID: 7640600 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]